ArticleJournal of health, population, and nutrition2025
The association between digestion-resistant and bioactive peptide content of dairy products and bladder cancer: a case-control study.
Article in Journal of health, population, and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBladder cancer is the sixth most common cancer worldwide. Bioactive peptides (BP) are digestion-resistant (enzymatically stable) and absorbable fragments that exert physiological functions in the body. We conducted this case-control study to examine the association between dairy-derived BPs and bladder cancer.
methodsThe present case-control study (103 cases and 200 controls) was a hospital-based investigation conducted in three referral hospitals in Tehran, Iran. Dietary intake was assessed using a validated 168-item Food Frequency Questionnaire (FFQ). Intake of BPs was estimated based on dairy product consumption recorded in the FFQ. Logistic regression analysis was used to examine the association between the content of digestion-resistant BPs in dairy products and the odds of bladder cancer.
resultsAfter adjusting confounding factors, it was observed that the odds of bladder cancer were significantly lower in the second and last tertiles (T) of total peptide intake from dairy products compared to the first tertile (T
conclusionsThe findings suggest a potential inverse relationship between milk-derived BPs and bladder cancer risk, which warrants further investigation in longitudinal or interventional studies. However, further studies are needed to elucidate the biological properties and mechanism of action of milk-derived BPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.